These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 8438355
1. Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts. Hayashi S, Ito M, Yokoyama I, Uchida K, Takagi H. Transplant Proc; 1993 Feb; 25(1 Pt 1):405-6. PubMed ID: 8438355 [No Abstract] [Full Text] [Related]
2. Evidence that combination therapy using cobra venom factor, splenectomy, and deoxyspergualin is effective in guinea pig to rat cardiac xenotransplantation. Hayashi S, Ito M, Yokoyama I, Takagi H. Transplantation; 1994 Mar 15; 57(5):777-9. PubMed ID: 8140648 [No Abstract] [Full Text] [Related]
3. Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor. Tavakoli R, Michel A, Cardoso J, Ayani E, Maillet F, Fontaliran F, Crougneau S, Weill B, Houssin D. Transplant Proc; 1993 Feb 15; 25(1 Pt 1):407-9. PubMed ID: 8438356 [No Abstract] [Full Text] [Related]
4. Vascular transplantation of Syrian hamster heart into Lewis rat: effect of brequinar, cyclosporine, cobra venom factor, and splenectomy. Schuurman HJ, Joergensen J, Kuipers H, Meerloo T, Lardelli P, Hiestand P, White DH, Schreier MH. Transplant Proc; 1994 Jun 15; 26(3):1217-9. PubMed ID: 8029893 [No Abstract] [Full Text] [Related]
5. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine. Scheringa M, Schraa EO, Bouwman E, van Dijk H, Melief MJ, Ijzermans JN, Marquet RL. Transplantation; 1995 Dec 15; 60(11):1350-3. PubMed ID: 8525534 [No Abstract] [Full Text] [Related]
6. Prolonged survival of guinea pig hearts in rats after combined antibody and complement depletion. Scheringa M, Blanker R, Bemelman M, Schraa E, de Bruin R, Bouwman E, IJzermans J, Marquet R. Transplant Proc; 1995 Feb 15; 27(1):303-4. PubMed ID: 7879011 [No Abstract] [Full Text] [Related]
7. Survival of hamster heart xenografts in rat recipients on a relatively mild immunosuppressive protocol. Scheringa M, Töns A, Bouwman E. Transplant Proc; 1996 Apr 15; 28(2):833-4. PubMed ID: 8623423 [No Abstract] [Full Text] [Related]
8. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats. Fryer JP, Chen S, Johnson EM, Simone P, Sun LH, Goswitz JJ, Matas AJ. Transplant Proc; 1996 Apr 15; 28(2):700. PubMed ID: 8623353 [No Abstract] [Full Text] [Related]
9. Additive effect of cyclosporine on guinea pig heart graft survival in complement-depleted rats. Scheringa M, Bouwman E, Schraa EO, Buchner B, de Bruin RW, IJzermans JN, Marquet RL. Transplant Proc; 1994 Apr 15; 26(2):1022-3. PubMed ID: 8171455 [No Abstract] [Full Text] [Related]
10. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. Candinas D, Lesnikoski BA, Robson SC, Scesney SM, Otsu I, Myiatake T, Marsh HC, Ryan US, Hancock WW, Bach FH. Transplant Proc; 1996 Apr 15; 28(2):581. PubMed ID: 8623282 [No Abstract] [Full Text] [Related]
11. Prolongation of concordant xenograft survival by a newly developed drug, FTY720. Fujiwara I, Nakajima H, Matsuda T, Mizuta N, Yamagishi H, Oka T. Transplant Proc; 1999 Nov 15; 31(7):2831-3. PubMed ID: 10578306 [No Abstract] [Full Text] [Related]
12. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Wang J, Morris RE. Transplant Proc; 1991 Feb 15; 23(1 Pt 1):699-702. PubMed ID: 1990655 [No Abstract] [Full Text] [Related]
13. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation. Thomas F, Araneda D, Quarantillo P. Transplant Proc; 1994 Jun 15; 26(3):1220-3. PubMed ID: 8029894 [No Abstract] [Full Text] [Related]
14. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Hancock WW, Blakely ML, Van der Werf W, Bach FH. Transplant Proc; 1993 Oct 15; 25(5):2932. PubMed ID: 8212288 [No Abstract] [Full Text] [Related]
16. Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. Carobbi A, Araneda D, Patselas T, Thomas J, Mosca F, Thomas F. Transplant Proc; 1991 Feb 15; 23(1 Pt 1):549-50. PubMed ID: 1703704 [No Abstract] [Full Text] [Related]
17. Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival. Carobbi A, Araneda D, Quarantillo P, Thomas JM, Thomas FT. Transplant Proc; 1992 Apr 15; 24(2):527. PubMed ID: 1373543 [No Abstract] [Full Text] [Related]
18. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation. Kemp E, Dieperink H, Leth P, Jensenius JC, Nielsen B, Lillevang ST, Salomon S, Steinbrüchel D, Larsen S, Koch C. Transplant Proc; 1994 Apr 15; 26(2):1011-5. PubMed ID: 8171451 [No Abstract] [Full Text] [Related]
19. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival. Pruitt SK, Halperin EC, Bollinger RR. Transplant Proc; 1991 Feb 15; 23(1 Pt 1):585-6. PubMed ID: 1990618 [No Abstract] [Full Text] [Related]
20. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation. Gannedahl G, Karlsson-Parra A, Tötterman TH, Tufveson G. Transplant Proc; 1993 Feb 15; 25(1 Pt 1):778-80. PubMed ID: 8438478 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]